Acute kidney injury is a serious condition that requires prompt medical attention to prevent complications and support recovery. Understanding treatment approaches—from standard supportive care to emerging therapies being tested in clinical trials—can help patients and families navigate this challenging diagnosis.

When the Kidneys Stop Working: Understanding Treatment Goals

When acute kidney injury strikes, the kidneys suddenly lose their ability to filter waste products and maintain the body’s delicate balance of fluids and chemicals. This can happen within hours or days, and without proper treatment, the consequences can be life-threatening. The primary goal of treatment is to identify and address the underlying cause while supporting the body until the kidneys can recover. This might involve restoring blood flow to the kidneys, treating infections, or removing blockages in the urinary system.^[1]

Treatment approaches must be tailored to each patient’s specific situation. The severity of kidney damage, underlying health conditions, age, and other factors all play important roles in determining the best course of action. Some people may recover quickly with minimal intervention, while others require more intensive support, including temporary dialysis. The good news is that many people with acute kidney injury do recover full or near-full kidney function, especially when the condition is caught early and treated promptly.^[2]

Modern medicine offers both established treatments that have been proven effective over time and experimental therapies being studied in clinical trials. While standard treatments focus on supporting the body and addressing immediate complications, researchers continue to search for medications and interventions that could directly protect the kidneys or speed up recovery. Understanding both approaches helps patients make informed decisions about their care.^[3]

Standard Treatment Approaches: Supporting Recovery

The foundation of treating acute kidney injury lies in addressing whatever caused the kidneys to fail in the first place. For many patients, this means treating the underlying problem while providing supportive care to help the body maintain balance until kidney function returns. Doctors must first determine whether the injury stems from reduced blood flow to the kidneys (called prerenal causes), damage within the kidneys themselves (intrinsic causes), or blockages preventing urine from draining (postrenal causes). Each type requires different management strategies.^[4]

When reduced blood flow is the culprit—often due to dehydration, blood loss, or heart problems—the primary treatment involves restoring adequate fluid volume and blood pressure. Healthcare providers typically use isotonic crystalloid solutions, such as normal saline or balanced salt solutions, to restore volume. These fluids are preferred over thicker solutions like albumin or dextrans because research has shown they work just as well without additional risks. The key is finding the right balance: providing enough fluid to support kidney function without overloading the body, which could cause dangerous swelling in the lungs or elsewhere.^[9][13]

Many medications can harm the kidneys, especially in people who are already sick or dehydrated. A crucial step in treatment is reviewing all medications the patient takes and stopping those that might be contributing to kidney damage. This includes common pain relievers called non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or naproxen, which can reduce blood flow to the kidneys. Blood pressure medications known as ACE inhibitors (names typically ending in “-pril”) or ARBs (ending in “-sartan”) may also need to be temporarily discontinued. Water pills called diuretics, which normally help remove excess fluid, can sometimes worsen kidney injury in dehydrated patients. Some antibiotics, particularly aminoglycosides, can directly damage kidney cells and should be avoided when possible.^[4][14]

When blockages in the urinary tract cause kidney injury, removing the obstruction is essential. In men, an enlarged prostate is a common culprit, while kidney stones, tumors, or other anatomical problems can affect anyone. Treatment might involve placing a thin tube called a urinary catheter to drain the bladder, or in some cases, more invasive procedures to remove stones or bypass blockages. Imaging studies, particularly ultrasound, help identify these obstructions so they can be addressed promptly.^[4][9]

Managing complications is another critical aspect of standard care. As waste products build up in the blood, patients may develop dangerously high levels of potassium (hyperkalemia), which can cause life-threatening heart rhythm problems. Doctors may prescribe medications to lower potassium levels or, in severe cases, recommend dialysis. Excess fluid accumulation can lead to swelling and difficulty breathing; in these situations, diuretics may be helpful, but only after adequate blood flow to the kidneys has been restored. Acid-base imbalances and other electrolyte disturbances must also be corrected to prevent further organ damage.^[2][6]

Nutritional support plays an often-overlooked but important role in recovery. Patients with acute kidney injury may need to follow special dietary restrictions to avoid overloading the kidneys with sodium, potassium, or phosphorus. Working with a dietitian helps ensure adequate nutrition while respecting these limitations. Protein needs must be carefully balanced—enough to support healing but not so much that it creates excessive waste products for struggling kidneys to filter. Blood sugar control is particularly important for people with diabetes, as high glucose levels can further damage kidney tissue.^[7][17]

In hospital settings, pharmacist-led programs have shown promise in reducing medication-related kidney injury. These programs involve reviewing each patient’s medications daily, checking for potential kidney-damaging drugs, and ensuring doses are adjusted appropriately for kidney function. Studies have demonstrated that such interventions can reduce the incidence of acute kidney injury and improve patient outcomes. Care bundles—coordinated sets of evidence-based practices—have also been associated with lower mortality rates and less progression to severe kidney failure.^[12]

When kidney function declines to dangerous levels despite these supportive measures, renal replacement therapy—commonly known as dialysis—becomes necessary. Dialysis is a temporary support system that performs the kidneys’ filtering function until they can recover. It removes excess fluid, eliminates waste products, and corrects chemical imbalances in the blood. The decision to start dialysis is based on several factors, including how high waste products have risen, whether the patient has life-threatening complications like uncontrollable potassium levels or fluid overload, and the trajectory of kidney function. Some patients need only a few dialysis sessions, while others require treatment for weeks or months.^[9][13]

The timing of dialysis initiation has been debated among specialists. Earlier research suggested that starting dialysis early, before severe complications develop, might improve outcomes. However, recent clinical trials have shown that waiting until clear indications emerge—what doctors call a “delayed” approach—results in similar survival rates while potentially avoiding unnecessary dialysis in patients whose kidneys recover on their own. This doesn’t mean delaying treatment when dialysis is clearly needed; rather, it means not rushing to start dialysis in stable patients whose kidney function might still improve with supportive care alone.^[13]

Emerging Treatments in Clinical Research

Despite decades of research, no specific medication has been proven to directly prevent or reverse acute kidney injury in most cases. This represents one of the biggest gaps in nephrology care and drives ongoing research into potential therapeutic targets. Scientists are investigating multiple approaches, from drugs that might protect kidney cells from damage to therapies that could speed up the repair process after injury occurs. While none of these treatments have yet become standard care, understanding what’s being studied offers hope for future advances.^[13]

Clinical trials represent the bridge between laboratory discoveries and real-world treatment. These carefully designed studies test whether new drugs or interventions are safe and effective before they can be approved for general use. Trials typically progress through three phases: Phase I studies test safety in small numbers of people, Phase II studies evaluate whether the treatment works and continue monitoring safety in larger groups, and Phase III trials compare the new treatment against current standard care in hundreds or thousands of patients. Only treatments that successfully complete all phases may be approved by regulatory agencies for widespread use.^[10]

Research into biomarkers—measurable substances in blood or urine that indicate kidney damage—has advanced significantly in recent years. While current diagnostic criteria rely on rising creatinine levels or decreasing urine output, these changes often appear hours or even days after injury has already occurred. Newer biomarkers, such as NGAL (neutrophil gelatinase-associated lipocalin), KIM-1 (kidney injury molecule-1), and others, can detect kidney damage much earlier. Although these tests are not yet widely used in routine clinical practice, they are being incorporated into research studies to identify high-risk patients who might benefit from early interventions or enrollment in clinical trials. The hope is that earlier detection will allow doctors to intervene before irreversible damage occurs.^[6][21]

Some research has focused on specific medications that might protect the kidneys in high-risk situations. For example, studies have examined whether statins—drugs commonly used to lower cholesterol—might reduce the risk of kidney injury in patients undergoing procedures with contrast dye, such as cardiac catheterization. High-dose statins have shown promise in reducing contrast-induced kidney injury in these settings, though more research is needed to confirm optimal dosing and identify which patients benefit most. This represents a potential preventive strategy rather than treatment after injury has occurred.^[12]

Researchers are also investigating whether certain existing medications might have kidney-protective properties beyond their primary uses. For instance, studies have explored whether drugs that affect blood vessel tone or reduce inflammation could minimize kidney damage in critically ill patients. The challenge lies in the complex nature of acute kidney injury, which can result from many different causes and mechanisms. A treatment that works for kidney injury caused by poor blood flow might not help when damage results from direct toxins or immune system reactions.^[13]

One area of active investigation involves optimizing blood pressure management in patients with or at risk for acute kidney injury. While maintaining adequate blood pressure is clearly important for kidney perfusion, the ideal target remains uncertain. Some studies have examined whether specific blood pressure medications, called vasopressors, might be better or worse for kidney outcomes. For example, there is ongoing debate about whether norepinephrine might be safer for the kidneys than other agents when treating critically ill patients who need blood pressure support. However, definitive evidence is still lacking.^[13]

Innovative approaches being explored in early-stage research include stem cell therapies that might help regenerate damaged kidney tissue, and drugs targeting specific molecular pathways involved in kidney cell death or inflammation. Some experimental treatments aim to enhance the kidney’s natural repair mechanisms, while others seek to prevent the progression from acute kidney injury to chronic kidney disease. These remain largely in preclinical or very early clinical testing, but they represent potential future directions for more targeted kidney injury treatment.^[13]

For certain specific causes of acute kidney injury, targeted therapies do exist or are under development. In cases where the immune system attacks the kidneys—such as in rapidly progressive glomerulonephritis—immunosuppressive medications like cyclophosphamide and prednisone can be lifesaving. For patients with hepatorenal syndrome (kidney failure resulting from severe liver disease), a medication called terlipressin has shown benefit in some countries, though it is not universally available. These represent examples where understanding the specific mechanism of kidney injury has led to mechanism-specific treatments.^[12][13]

Prevention research has also gained momentum, particularly focused on identifying and protecting high-risk patients before kidney injury develops. Studies have examined strategies such as careful monitoring of at-risk hospitalized patients, avoiding unnecessary nephrotoxic drug combinations, and ensuring adequate hydration before procedures that might stress the kidneys. The concept of care bundles—coordinated sets of preventive measures implemented together—has shown promise in reducing the incidence of hospital-acquired acute kidney injury. These bundles typically include elements like medication review, hydration protocols, and enhanced monitoring of kidney function in vulnerable patients.^[21]

International research efforts continue to enroll patients in studies examining various aspects of acute kidney injury management. These trials are conducted at major medical centers in North America, Europe, and other regions around the world. Eligibility criteria vary depending on the specific study but generally require meeting certain diagnostic criteria for acute kidney injury, having specific underlying causes, or being in particular high-risk groups. Patients interested in participating should ask their healthcare providers about available studies or search clinical trial registries for relevant research opportunities.^[10]

Most Common Treatment Methods

• Fluid Management and Resuscitation
  • Administration of isotonic crystalloid solutions (normal saline or balanced salt solutions) to restore blood volume in cases of dehydration or reduced blood flow to kidneys
  • Careful monitoring of fluid balance to avoid overload while maintaining adequate kidney perfusion
  • Use of balanced crystalloids preferred over colloid solutions based on clinical evidence
• Medication Adjustment and Avoidance
  • Discontinuation of nephrotoxic medications including NSAIDs (ibuprofen, naproxen)
  • Temporary cessation of ACE inhibitors, ARBs, and certain diuretics when appropriate
  • Avoidance of aminoglycoside antibiotics and other drugs that directly damage kidney cells
  • Dose adjustment of necessary medications based on reduced kidney function
• Treatment of Underlying Causes
  • Antibiotics for infections or sepsis causing kidney injury
  • Removal of urinary tract obstructions through catheterization or surgical procedures
  • Management of heart failure or other conditions reducing blood flow to kidneys
  • Immunosuppressive therapy (cyclophosphamide, prednisone) for immune-mediated kidney damage
• Management of Complications
  • Treatment of hyperkalemia (high potassium) to prevent cardiac complications
  • Use of diuretics to manage fluid overload in appropriate cases
  • Correction of acid-base imbalances and other electrolyte disturbances
  • Blood pressure support with vasopressors when needed
• Renal Replacement Therapy (Dialysis)
  • Hemodialysis to filter blood and remove waste products when kidneys cannot function adequately
  • Temporary support provided until kidney function recovers
  • Indicated for severe hyperkalemia, volume overload, intractable acidosis, uremic complications, or certain toxic exposures
  • Regional citrate anticoagulation often preferred during dialysis procedures
• Nutritional Support and Dietary Management
  • Special diets limiting sodium, potassium, and phosphorus intake
  • Balanced protein intake to support healing without creating excessive waste products
  • Consultation with dietitians to create kidney-friendly meal plans
  • Careful blood sugar control, especially in patients with diabetes
• Preventive Care Bundles
  • Pharmacist-led medication review programs in hospital settings
  • Enhanced monitoring protocols for high-risk patients
  • Coordinated evidence-based practices to reduce iatrogenic (treatment-caused) kidney injury
  • Early identification of vulnerable patients using risk assessment tools